MRx-4DP0004

DRUG2 trials

Sponsors

4D pharma plc

Conditions

AsthmaCOVID-19

Phase 1

A Study of MRx-4DP0004 in Asthma

TerminatedNCT03851250

4D pharma plcAsthma

Start: 2019-07-04End: 2023-04-26Updated: 2024-04-17

Phase 2

A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19

WithdrawnNCT04363372

4D pharma plcCOVID-19

Start: 2020-08-31End: 2021-01-31Updated: 2021-06-16